Nautilus Biotechnology Inc Total Liabilities
Nautilus Biotechnology Inc total liabilities. Based on the latest financial reports, Nautilus Biotechnology Inc (NAUT) has total liabilities worth $32.46 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NAUT asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Nautilus Biotechnology Inc (2018–2025)
Total liabilities of Nautilus Biotechnology Inc from 2018 to 2025. This chart illustrates how Nautilus Biotechnology Inc's total liabilities have evolved over time, based on quarterly financial data. Explore NAUT strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Nautilus Biotechnology Inc Competitors by Total Liabilities
The table below lists competitors of Nautilus Biotechnology Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ammo Inc
NASDAQ:POWW
|
USA | $34.86 Million |
|
Launchpad Cadenza Acquisition Corp I Class A Ordinary Share
NASDAQ:LPCV
|
USA | $11.06 Million |
|
BTB Real Estate Investment Trust
TO:BTB-UN
|
Canada | CA$752.95 Million |
|
Compucase Enterprise Co Ltd
TW:3032
|
Taiwan | NT$14.44 Billion |
|
Zhejiang Prulde Electric Appliance Co. Ltd. A
SHE:301353
|
China | CN¥233.49 Million |
|
Australian Strategic Materials Ltd
AU:ASM
|
Australia | AU$38.00 Million |
|
Doubleview Gold Corp
V:DBG
|
Canada | CA$1.67 Million |
|
Huasi Agricultural Development Co Ltd
SHE:002494
|
China | CN¥266.61 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Nautilus Biotechnology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Nautilus Biotechnology Inc's balance sheet.
Liquidity & Leverage Metrics
Nautilus Biotechnology Inc Total Liabilities Ratios Explained
Nautilus Biotechnology Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nautilus Biotechnology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nautilus Biotechnology Inc (2018–2025)
The table below shows the annual total liabilities of Nautilus Biotechnology Inc from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $34.14 Million | +0.37% |
| 2024-12-31 | $34.01 Million | -15.42% |
| 2023-12-31 | $40.21 Million | +14.47% |
| 2022-12-31 | $35.13 Million | +0.73% |
| 2021-12-31 | $34.87 Million | -69.60% |
| 2020-12-31 | $114.73 Million | +23314.69% |
| 2019-12-31 | $490.00K | -99.65% |
| 2018-12-31 | $140.82 Million | -- |
About Nautilus Biotechnology Inc
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument,… Read more